9th Annual Biomarkers Congress

View Profile


Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2012 Gallbladder/Biliary Tract. In: Oncologic Imaging for the Practicing Radiologist, Medical Oncologist and Surgeon Elsevier,
2. 2012 Liver. In: Oncologic Imaging for the Practicing Radiologist, Medical Oncologist and Surgeon. Elsevier
3. 2010 “The Future: Combination Systemic Therapy for Hepatocellular Carcinoma” in: Hepatocellular Carcinoma: A Multidisciplinary Approach. Humana Press (2010). Editors: Kelly M. McMasters and Jean-Nicolas Vauthey.
4. 2010 “Epidemiology and Pathogenesis of Hepatocellular Carcinoma” in: Hepatocellular Carcinoma: A Multidisciplinary Approach. Humana Press (2010). Editors: Kelly M. McMasters and Jean-Nicolas Vauthey
5. 2010 Duration of Diabetes and type of diabetes treatment, increase the risk of hepatocellular carcinoma. Cancer ;116(8):1938-46.
6. 2010 Chapter 15; Hepatobiliary cancers. 2nd edition of the M.D. Anderson Manual of Medical Oncology. McGraw-Hill In Press 2010. Editors: Hagop M. Kantarjian, Charles A. Koller, and Robert A. Wolff.
7. 2010 Pretreatment assessment of hepatocellular cancer: expert consensus conference. HPB (Oxford) ;12(5):300-1.
8. 2010 A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer Invest New Drugs
9. 2009 Gallbladder and Bile Duct Cancer Chapter 90 the Eighth Edition of Cancer Medicine
10. 2009 Antitumor Activity of Gemcitabine and Oxaliplatin Is Augmented by Thymoquinone in Pancreatic Cancer. Cancer Res 2009; 69
11. 2009 Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States Hepatology ;49(5):1563-70.
12. 2009 Vascular Endothelial Growth Factor (VEGF) in the management of hepatocellular carcinoma. A Review of Literature. Cancer. Cancer
13. 2009 Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival Surgery;145(4):399-405
14. 2009 A Phase II trial of the combination of bevacizumab and erlotinib in patients with advanced hepatocellular carcinoma J Clin Oncol ;27(6):843-50.
15. 2009 Molecular Targets and Therapeutic uses of Kalonji (Thymoquinone)” in “Molecular Targets and Therapeutic uses of Spices: Modern Uses for Ancient Medicine World Scientific Publishing Co., Inc,
16. 2009 Chemotherapy and Novel Therapies” in: Hepatocellular Carcinoma: A Practical Approach Informa Health Care Publishing Co. Inc., United Kingdom (2009) Editors: Boloni, L; Reddy, K; Al Knawy, B.
17. 2008 Utility of animal models in pancreatic cancer research. Pancreatic Cancer, Lowy, Leach and Philip (Eds) Chapter 34. Springer, New York, NY, USA pp 577-599,
18. 2008 Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study J Cancer ;123(8):1883-91.
19. 2008 The association of family history of liver cancer with hepatocellular carcinoma: USA case-control study J Hepatol
20. 2007 Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer Cancer Res 67:7782-8
21. 2007 Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine Proc Natl Acad Sci U S A 104:2343-8
22. 2006 Vaccines in Medical Oncology”, “Biological Response Modifiers in Cancer Therapy”, and “Cancer Gene Therapy” in: Contemporary Perspectives on Clinical Pharmacotherapeutics Elsevier Publishing Co. Inc. Editors: Kohli, K
23. 2005 Sensitive detection of Human Papilloma virus in cervical, head/neck and schistosomiasis-associated bladder. Proc Natl Acad Sci USA 102:7683-8


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.